It can be difficult to treat non-melanoma skin cancer (NMSC) of the lower legs. The blood supply of the lower legs makes surgery challenging, and radiotherapy below the knee is controversial because of the fear of radiation-induced ulcers. In the study, "Lesion-based...
Hear from our CEO, Adrian Treverton, about treating non-melanoma skin cancer patients safely during COVID. Patients most likely to develop basal or squamous cell carcinoma are those in the age range at greater risk of serious illness from COVID, so safe and short...
One common question dermatologists often ask about incorporating radiation therapy into their practice is “How much involvement do I need from a radiation oncologist?” Regulations concerning physician supervision, reimbursement, and radiation shielding can vary quite...
Skin cancer is an increasingly common condition, particularly keratinocytic cancers like basal cell carcinoma and cutaneous squamous cell carcinoma. Surgery has been the standard treatment for these, but affects functional and/or cosmetic outcomes. Definitive...
Non-melanoma skin cancer is the most common cancer in the world today, with approximately 1.5 million cases in 2016—and that number is growing rapidly. While this type of cancer has a low morbidity rate, surgical treatment often leaves patients with dysfunctions,...
In this webcast, Dr. Richard Shaffer presents on a range of clinical conditions that can be treated with superficial-orthovoltage radiotherapy machines. The presentation primarily focuses on the treatment of non-melanoma skin cancer, including several illustrative...
Explore the case study below, which highlights how simple RADiant makes treatment of both squamous cell carcinoma and basal cell carcinoma lesions in the dermatology clinic setting.
Superficial and orthovoltage therapy are convenient and effective ways to treat non-melanoma skin cancer. Learn why these options are better for both the patient and the treatment provider. https://vimeo.com/718424700
This study, Hypofractionated Radiotherapy in Older Patients with Non-melanoma Skin Cancer: Less is Better, explores how our Xstrahl 300 system was used to successfully treat NMSC for 3 older patients. See the full study here, and more details below.
Contact Us